MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00231764
Recruitment Status : Completed
First Posted : October 4, 2005
Last Update Posted : April 24, 2008
Prof. Philip Halloran, Edmonton, Canada (sponsor)
Prof. Yves Vanrenterghem, Leuven, Belgium (Steering Committee Member)
Prof. Pierre Daloze, Montréal, Canada (Steering Committee Member)
Prof. Thomas C. Pearson, Atlanta, USA (Steering Committee Member)
Prof. Ulrich Frei, Berlin, Germany (Steering Committee Member)
Prof. Flavio Vincenti, San Francisco, USA (Ass. Steering Committee Member)
Prof. Josep Grinyo, Barcelona, Spain (Ass. Steering Committee Member)
Hoffmann-La Roche
Information provided by:
Ekberg, Henrik, M.D.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2006
  Actual Study Completion Date : February 2008